Tenax Therapeutics (TENX) Enterprise Value (2016 - 2017)
Tenax Therapeutics' Enterprise Value history spans 8 years, with the latest figure at -$8.5 million for Q3 2017.
- For Q3 2017, Enterprise Value fell 14.13% year-over-year to -$8.5 million; the TTM value through Sep 2017 reached -$8.5 million, down 14.13%, while the annual FY2016 figure was -$13.3 million, N/A changed from the prior year.
- Enterprise Value for Q3 2017 was -$8.5 million at Tenax Therapeutics, up from -$8.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$828811.0 in Q1 2013 and bottomed at -$58.3 million in Q2 2014.
- The 5-year median for Enterprise Value is -$8.8 million (2017), against an average of -$13.7 million.
- The largest annual shift saw Enterprise Value soared 86.41% in 2015 before it crashed 283.87% in 2017.
- A 5-year view of Enterprise Value shows it stood at -$828811.0 in 2013, then plummeted by 6936.65% to -$58.3 million in 2014, then soared by 65.38% to -$20.2 million in 2015, then soared by 34.22% to -$13.3 million in 2016, then surged by 35.74% to -$8.5 million in 2017.
- Per Business Quant, the three most recent readings for TENX's Enterprise Value are -$8.5 million (Q3 2017), -$8.8 million (Q2 2017), and -$12.5 million (Q1 2017).